Home / Business and Economy / Intuitive Surgical: A 44% Drop and a Bold Rebound Bet
Intuitive Surgical: A 44% Drop and a Bold Rebound Bet
28 Jul
Summary
- Intuitive Surgical stock dropped 44% from its peak, its second-largest decline.
- Analysts are bullish, with 71% rating the stock as a buy.
- The new da Vinci 5 system shows increased hospital efficiency and sales.
Intuitive Surgical, a leader in robotic-assisted surgery, has experienced a substantial 44% stock price decrease from its high, marking its second-largest decline in the past decade. Despite this dip, Wall Street analysts largely maintain a positive outlook, with 71% recommending the stock as a buy.
The company's innovative da Vinci robotics platform continues to evolve. The recent FDA approval of the da Vinci 5 system in March 2024 has bolstered sales, with a higher mix of these advanced systems driving increased average prices and unit utilization in hospitals.
Beyond system sales, Intuitive Surgical's business model relies on recurring revenue from parts, services, and maintenance, akin to a razor-and-blade strategy. This recurring revenue stream, coupled with the growing adoption and efficiency gains from the da Vinci 5, underpins analysts' confidence in the stock's rebound potential.
